He S, Kahles F, Rattik S, Nairz M, McAlpine CS, Anzai A, et al
In the initial study of semaglutide, in the second year patients lost on average an extra 8% of their body weight
NCCIH and NIH-affiliated researchers are clear that the optimal protein targets and training protocols during GLP-1 therapy are still being studied - the LEAN-PREP study and the GRAMS trial at Pennington Biomedical Research Center are both actively recruiting as of 2026
After exercise, the body is more responsive to nutrients a well-balanced meal with protein, fiber, and healthy fats during this post-workout window may further stimulate GLP-1 and support appetite regulation and metabolic health
That has been completely debunked
Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes